SOMERVILLE, Mass., Feb. 26, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (Nasdaq: GENB) ("Generate"), a clinical-stage generative biology company pioneering the AI revolution in biotechnology and ...
Integrating Generate’s waste-to-value solutions businesses into a single platform enables more comprehensive sustainability and climate solutions, supporting market acceleration SAN ...
Gone are the days where seven touchpoints with a potential customer would be enough to convert them. Now, you need between 20 and 500. Someone has to feel familiar with your work, your vibe, even your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results